Rank | Gene Set | Z-score |
---|---|---|
1 | L-alpha-amino acid transmembrane transport (GO:1902475) | 7.21431822 |
2 | axon ensheathment in central nervous system (GO:0032291) | 6.19052934 |
3 | central nervous system myelination (GO:0022010) | 6.19052934 |
4 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 6.10822105 |
5 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 6.10822105 |
6 | regulation of translation, ncRNA-mediated (GO:0045974) | 6.10822105 |
7 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 5.66914492 |
8 | fatty acid elongation (GO:0030497) | 5.55612378 |
9 | pre-miRNA processing (GO:0031054) | 5.40531335 |
10 | L-serine metabolic process (GO:0006563) | 5.38322871 |
11 | positive regulation by symbiont of host defense response (GO:0052509) | 4.99344483 |
12 | modulation by symbiont of host defense response (GO:0052031) | 4.99344483 |
13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.99344483 |
14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.99344483 |
15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.99344483 |
16 | modulation by symbiont of host immune response (GO:0052553) | 4.99344483 |
17 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.59856529 |
18 | regulation of gene silencing (GO:0060968) | 4.53018069 |
19 | nodal signaling pathway (GO:0038092) | 4.48402420 |
20 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 4.42395920 |
21 | response to lipoprotein particle (GO:0055094) | 4.39365671 |
22 | regulation of cell fate specification (GO:0042659) | 4.33209026 |
23 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.31999869 |
24 | lysine catabolic process (GO:0006554) | 4.31230064 |
25 | lysine metabolic process (GO:0006553) | 4.31230064 |
26 | response to methylmercury (GO:0051597) | 4.29546199 |
27 | regulation of mitotic spindle checkpoint (GO:1903504) | 4.20048305 |
28 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 4.20048305 |
29 | negative regulation of gene silencing (GO:0060969) | 4.17745624 |
30 | basic amino acid transport (GO:0015802) | 4.12565320 |
31 | heme transport (GO:0015886) | 4.10787288 |
32 | IMP biosynthetic process (GO:0006188) | 4.10394704 |
33 | microglial cell activation (GO:0001774) | 4.10238936 |
34 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.07237072 |
35 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.03675713 |
36 | transcytosis (GO:0045056) | 3.99315448 |
37 | regulation of helicase activity (GO:0051095) | 3.98264939 |
38 | cholesterol biosynthetic process (GO:0006695) | 3.96388882 |
39 | regulation of chromatin silencing (GO:0031935) | 3.94816903 |
40 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.87946537 |
41 | regulation of cell fate commitment (GO:0010453) | 3.84827980 |
42 | neutrophil activation involved in immune response (GO:0002283) | 3.84607254 |
43 | ensheathment of neurons (GO:0007272) | 3.84353542 |
44 | axon ensheathment (GO:0008366) | 3.84353542 |
45 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.83777475 |
46 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.83777475 |
47 | myelination (GO:0042552) | 3.79521015 |
48 | anterior/posterior axis specification, embryo (GO:0008595) | 3.78012649 |
49 | negative regulation of telomerase activity (GO:0051974) | 3.77766818 |
50 | regulation of SMAD protein import into nucleus (GO:0060390) | 3.77653253 |
51 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.75224144 |
52 | macrophage activation involved in immune response (GO:0002281) | 3.71240873 |
53 | protein complex localization (GO:0031503) | 3.69540722 |
54 | plasma lipoprotein particle clearance (GO:0034381) | 3.69283005 |
55 | L-phenylalanine catabolic process (GO:0006559) | 3.68846449 |
56 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.68846449 |
57 | kynurenine metabolic process (GO:0070189) | 3.66543331 |
58 | single strand break repair (GO:0000012) | 3.65783343 |
59 | IMP metabolic process (GO:0046040) | 3.64711055 |
60 | sterol biosynthetic process (GO:0016126) | 3.60838982 |
61 | lung-associated mesenchyme development (GO:0060484) | 3.60672324 |
62 | negative regulation of androgen receptor signaling pathway (GO:0060766) | 3.59663739 |
63 | amyloid precursor protein metabolic process (GO:0042982) | 3.58146453 |
64 | regulation of mesoderm development (GO:2000380) | 3.56788622 |
65 | tryptophan catabolic process (GO:0006569) | 3.47524427 |
66 | indole-containing compound catabolic process (GO:0042436) | 3.47524427 |
67 | indolalkylamine catabolic process (GO:0046218) | 3.47524427 |
68 | creatine metabolic process (GO:0006600) | 3.47197515 |
69 | regulation of collateral sprouting (GO:0048670) | 3.46427340 |
70 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.46328635 |
71 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.45792327 |
72 | regulation of histone H3-K9 methylation (GO:0051570) | 3.43025405 |
73 | L-phenylalanine metabolic process (GO:0006558) | 3.38485459 |
74 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.38485459 |
75 | inner ear receptor cell development (GO:0060119) | 3.30044567 |
76 | low-density lipoprotein particle clearance (GO:0034383) | 3.29572990 |
77 | * import into cell (GO:0098657) | 3.27960678 |
78 | very long-chain fatty acid metabolic process (GO:0000038) | 3.26067261 |
79 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.25055971 |
80 | protein carboxylation (GO:0018214) | 3.25055971 |
81 | atrial cardiac muscle cell action potential (GO:0086014) | 3.24157023 |
82 | amyloid precursor protein catabolic process (GO:0042987) | 3.23227534 |
83 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.22641030 |
84 | serine family amino acid catabolic process (GO:0009071) | 3.21665115 |
85 | sulfation (GO:0051923) | 3.20691684 |
86 | glycosylceramide metabolic process (GO:0006677) | 3.17174327 |
87 | regulation of DNA methylation (GO:0044030) | 3.16437859 |
88 | cholesterol efflux (GO:0033344) | 3.14477470 |
89 | cofactor catabolic process (GO:0051187) | 3.12908622 |
90 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.11614560 |
91 | N-acetylglucosamine metabolic process (GO:0006044) | 3.11525536 |
92 | kidney morphogenesis (GO:0060993) | 3.11485728 |
93 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.11350838 |
94 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.03266159 |
95 | aspartate family amino acid catabolic process (GO:0009068) | 3.02307041 |
96 | negative regulation of histone methylation (GO:0031061) | 3.02156338 |
97 | mannose metabolic process (GO:0006013) | 3.02013191 |
98 | myelin maintenance (GO:0043217) | 3.00173767 |
99 | iron coordination entity transport (GO:1901678) | 2.99394800 |
100 | glomerular visceral epithelial cell development (GO:0072015) | 2.98726166 |
101 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.97512986 |
102 | purine nucleobase biosynthetic process (GO:0009113) | 2.96098591 |
103 | positive regulation of catenin import into nucleus (GO:0035413) | 2.95358284 |
104 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.92967893 |
105 | aldehyde catabolic process (GO:0046185) | 2.92923902 |
106 | oligosaccharide catabolic process (GO:0009313) | 2.92755187 |
107 | regulation of hippo signaling (GO:0035330) | 2.91518196 |
108 | alpha-linolenic acid metabolic process (GO:0036109) | 2.90026996 |
109 | * L-amino acid import (GO:0043092) | 2.89283364 |
110 | tryptophan metabolic process (GO:0006568) | 2.88277503 |
111 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.88067127 |
112 | macrophage activation (GO:0042116) | 2.87921573 |
113 | regulation of stem cell maintenance (GO:2000036) | 2.86311576 |
114 | complement activation, alternative pathway (GO:0006957) | 2.86090263 |
115 | glycerophospholipid catabolic process (GO:0046475) | 2.84622576 |
116 | negative regulation of telomere maintenance (GO:0032205) | 2.83864473 |
117 | intracellular pH reduction (GO:0051452) | 2.83118892 |
118 | glycosphingolipid catabolic process (GO:0046479) | 2.82917456 |
119 | fibrinolysis (GO:0042730) | 2.82886207 |
120 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.82826127 |
121 | heterochromatin organization (GO:0070828) | 2.82491872 |
122 | regulation of lipoprotein metabolic process (GO:0050746) | 2.79032787 |
123 | isoprenoid biosynthetic process (GO:0008299) | 2.77426750 |
124 | protein-lipid complex assembly (GO:0065005) | 2.75768034 |
125 | regulation of cholesterol storage (GO:0010885) | 2.75317241 |
126 | negative regulation of macroautophagy (GO:0016242) | 2.75215919 |
127 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.74465172 |
128 | positive regulation of cholesterol efflux (GO:0010875) | 2.73895811 |
129 | telomere maintenance via telomerase (GO:0007004) | 2.73887366 |
130 | nucleobase biosynthetic process (GO:0046112) | 2.71796780 |
131 | respiratory burst (GO:0045730) | 2.70906803 |
132 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.70575377 |
133 | indolalkylamine metabolic process (GO:0006586) | 2.70547093 |
134 | positive regulation of hemostasis (GO:1900048) | 2.70011495 |
135 | positive regulation of blood coagulation (GO:0030194) | 2.70011495 |
136 | regulation of mononuclear cell migration (GO:0071675) | 2.69518782 |
137 | negative regulation of cell fate commitment (GO:0010454) | 2.68701489 |
138 | cell migration involved in gastrulation (GO:0042074) | 2.68591950 |
139 | NAD biosynthetic process (GO:0009435) | 2.67897504 |
140 | positive regulation of coagulation (GO:0050820) | 2.67774780 |
141 | * cholesterol metabolic process (GO:0008203) | 2.66888450 |
142 | ncRNA catabolic process (GO:0034661) | 2.66848742 |
143 | response to host immune response (GO:0052572) | 2.66396765 |
144 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.66396765 |
145 | positive regulation of chemokine secretion (GO:0090197) | 2.66151261 |
146 | female gonad development (GO:0008585) | 2.66146695 |
147 | phagocytosis, engulfment (GO:0006911) | 2.65873077 |
148 | response to xenobiotic stimulus (GO:0009410) | 2.64459583 |
149 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.64368843 |
150 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.63728380 |
151 | plasma lipoprotein particle assembly (GO:0034377) | 2.63405161 |
152 | response to cholesterol (GO:0070723) | 2.61956773 |
153 | chromatin silencing (GO:0006342) | 2.61513557 |
154 | aromatic amino acid family catabolic process (GO:0009074) | 2.59134043 |
155 | N-acetylneuraminate metabolic process (GO:0006054) | 2.58303302 |
156 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.57972043 |
157 | cellular response to cholesterol (GO:0071397) | 2.57939141 |
158 | positive regulation of osteoblast proliferation (GO:0033690) | 2.57345263 |
159 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.56517774 |
160 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.56274903 |
161 | adhesion of symbiont to host cell (GO:0044650) | 2.55975724 |
162 | virion attachment to host cell (GO:0019062) | 2.55975724 |
163 | cofactor transport (GO:0051181) | 2.54773719 |
164 | dorsal/ventral axis specification (GO:0009950) | 2.54427367 |
165 | mitotic G2/M transition checkpoint (GO:0044818) | 2.54235221 |
166 | pH reduction (GO:0045851) | 2.54145881 |
167 | regulation of meiosis I (GO:0060631) | 2.53970266 |
168 | regulation of protein activation cascade (GO:2000257) | 2.53521073 |
169 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.53503610 |
170 | organ growth (GO:0035265) | 2.53420261 |
171 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.52846398 |
172 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.52846398 |
173 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.52846398 |
174 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.52846398 |
175 | negative regulation of sister chromatid segregation (GO:0033046) | 2.52846398 |
176 | serine family amino acid biosynthetic process (GO:0009070) | 2.52229028 |
177 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.51787740 |
178 | response to thyroid hormone (GO:0097066) | 2.51177532 |
179 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.51148196 |
180 | regulation of cholesterol esterification (GO:0010872) | 2.51093282 |
181 | histone H3-K36 demethylation (GO:0070544) | 2.50516161 |
182 | response to lead ion (GO:0010288) | 2.50484112 |
183 | bile acid biosynthetic process (GO:0006699) | 2.50382130 |
184 | glycolipid catabolic process (GO:0019377) | 2.50260597 |
185 | phospholipid efflux (GO:0033700) | 2.50205929 |
186 | L-ascorbic acid metabolic process (GO:0019852) | 2.50135236 |
187 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.49044292 |
188 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.49044292 |
189 | vitamin biosynthetic process (GO:0009110) | 2.48893960 |
190 | positive regulation of antigen processing and presentation (GO:0002579) | 2.46696606 |
191 | response to X-ray (GO:0010165) | 2.46194253 |
192 | folic acid transport (GO:0015884) | 2.45956404 |
193 | regulation of complement activation (GO:0030449) | 2.45713843 |
194 | regulation of cholesterol metabolic process (GO:0090181) | 2.44787938 |
195 | positive regulation of interferon-alpha production (GO:0032727) | 2.44029797 |
196 | * sterol metabolic process (GO:0016125) | 2.43956645 |
197 | regulation of gene silencing by RNA (GO:0060966) | 10.0587968 |
198 | regulation of posttranscriptional gene silencing (GO:0060147) | 10.0587968 |
199 | regulation of gene silencing by miRNA (GO:0060964) | 10.0587968 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.11401210 |
2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.57218357 |
3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.73076010 |
4 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.70956245 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.55864920 |
6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.44453075 |
7 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 3.43457929 |
8 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.38145760 |
9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.23609690 |
10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.21787586 |
11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.12616223 |
12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.09901648 |
13 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.04315600 |
14 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.87966255 |
15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.77752466 |
16 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.73321012 |
17 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.63262938 |
18 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 2.59394157 |
19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54632082 |
20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.47639793 |
21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.43702515 |
22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.34179739 |
23 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.34157291 |
24 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 2.34116346 |
25 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.34116346 |
26 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 2.31653977 |
27 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.31011930 |
28 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.25494831 |
29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.20450962 |
30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.13064513 |
31 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 2.13046620 |
32 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.12341288 |
33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.08252368 |
34 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 2.07521867 |
35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.06291172 |
36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.05301168 |
37 | GATA1_22025678_ChIP-Seq_K562_Human | 2.04545297 |
38 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.02014923 |
39 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.99340021 |
40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.92464478 |
41 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.92230517 |
42 | * GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.91948139 |
43 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.91103612 |
44 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.86949178 |
45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.85762948 |
46 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.84711592 |
47 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.82517951 |
48 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.82285588 |
49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.77863919 |
50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.75948702 |
51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.75554233 |
52 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.70085432 |
53 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.67255268 |
54 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.67255268 |
55 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.66322071 |
56 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.64923076 |
57 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.63346764 |
58 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.63281174 |
59 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.61085445 |
60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60969778 |
61 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.55606522 |
62 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.55252274 |
63 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55220656 |
64 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.51150170 |
65 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.51001522 |
66 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.50393408 |
67 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.50277539 |
68 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.49846739 |
69 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.49807610 |
70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49219761 |
71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48021536 |
72 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.47043730 |
73 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.45979923 |
74 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.44032409 |
75 | EWS_26573619_Chip-Seq_HEK293_Human | 1.41224177 |
76 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.38202040 |
77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.37173605 |
78 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.36920311 |
79 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.36511981 |
80 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34212413 |
81 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.32764351 |
82 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.30268325 |
83 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29466093 |
84 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.28474455 |
85 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27292940 |
86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25996930 |
87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.25601946 |
88 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25351341 |
89 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.23267570 |
90 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.22674625 |
91 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.22166546 |
92 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.21197936 |
93 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20996029 |
94 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.20254714 |
95 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.19711850 |
96 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.18708942 |
97 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.18598467 |
98 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.18047417 |
99 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.17923185 |
100 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.17565768 |
101 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.15565377 |
102 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.14931305 |
103 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.14909292 |
104 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.14279406 |
105 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13780725 |
106 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11668163 |
107 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.10011375 |
108 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09806690 |
109 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.09778709 |
110 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09738547 |
111 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.09659590 |
112 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.09493746 |
113 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09223158 |
114 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06822601 |
115 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.06413296 |
116 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.05950137 |
117 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.04706540 |
118 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.04074274 |
119 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03161859 |
120 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.02856583 |
121 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02807825 |
122 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02189339 |
123 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.00847112 |
124 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00736408 |
125 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.00518901 |
126 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.99895504 |
127 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.99895504 |
128 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96974754 |
129 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95916489 |
130 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.94761049 |
131 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94567581 |
132 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94556464 |
133 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.94484791 |
134 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.94101119 |
135 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.93753609 |
136 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93416094 |
137 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.93391243 |
138 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.93022251 |
139 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.92797461 |
140 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92736858 |
141 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.91354509 |
142 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88458822 |
143 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.87156964 |
144 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.87156964 |
145 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.87156964 |
146 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.87044176 |
147 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.86629535 |
148 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85813049 |
149 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.85304994 |
150 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84662960 |
151 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83042908 |
152 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.82569417 |
153 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.82346146 |
154 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.82194326 |
155 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.82053087 |
156 | KDM2B_26808549_Chip-Seq_REH_Human | 0.81949857 |
157 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.80579103 |
158 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.80542170 |
159 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.80162820 |
160 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.80129217 |
161 | SPI1_23127762_ChIP-Seq_K562_Human | 0.79864578 |
162 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.79539553 |
163 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.78878258 |
164 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.78878258 |
165 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.78025665 |
166 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.77885320 |
167 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77773399 |
168 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.77687531 |
169 | RXR_22108803_ChIP-Seq_LS180_Human | 0.77661904 |
170 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.76999581 |
171 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76753604 |
172 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.76378132 |
173 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.76095645 |
174 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74404680 |
175 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74079804 |
176 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73755348 |
177 | TP53_16413492_ChIP-PET_HCT116_Human | 0.71845682 |
178 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.69028458 |
179 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.66619352 |
180 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.65673416 |
181 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63916335 |
182 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.63628688 |
183 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.63627505 |
184 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.63281465 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002254_reproductive_system_inflammat | 8.54202723 |
2 | MP0009840_abnormal_foam_cell | 5.29210781 |
3 | MP0003941_abnormal_skin_development | 5.05617570 |
4 | MP0005058_abnormal_lysosome_morphology | 4.94846271 |
5 | MP0003690_abnormal_glial_cell | 4.19534085 |
6 | * MP0000920_abnormal_myelination | 3.62681273 |
7 | MP0006082_CNS_inflammation | 3.35210115 |
8 | MP0003890_abnormal_embryonic-extraembry | 3.33106146 |
9 | MP0003191_abnormal_cellular_cholesterol | 3.27074131 |
10 | MP0003950_abnormal_plasma_membrane | 3.19351371 |
11 | MP0004133_heterotaxia | 2.92755221 |
12 | MP0003656_abnormal_erythrocyte_physiolo | 2.92157503 |
13 | MP0008877_abnormal_DNA_methylation | 2.81707533 |
14 | MP0003195_calcinosis | 2.76926463 |
15 | MP0000604_amyloidosis | 2.69767783 |
16 | MP0002139_abnormal_hepatobiliary_system | 2.62836257 |
17 | MP0003172_abnormal_lysosome_physiology | 2.58473450 |
18 | MP0003806_abnormal_nucleotide_metabolis | 2.51466660 |
19 | MP0003646_muscle_fatigue | 2.49285222 |
20 | MP0005451_abnormal_body_composition | 2.45178226 |
21 | MP0008260_abnormal_autophagy | 2.38023925 |
22 | MP0005360_urolithiasis | 2.32987017 |
23 | MP0003693_abnormal_embryo_hatching | 2.27863207 |
24 | MP0008438_abnormal_cutaneous_collagen | 2.24932508 |
25 | MP0005085_abnormal_gallbladder_physiolo | 2.08592630 |
26 | MP0008875_abnormal_xenobiotic_pharmacok | 2.05543225 |
27 | MP0000579_abnormal_nail_morphology | 2.05526800 |
28 | MP0005365_abnormal_bile_salt | 2.02612776 |
29 | MP0009278_abnormal_bone_marrow | 2.01970623 |
30 | MP0005377_hearing/vestibular/ear_phenot | 1.99268058 |
31 | MP0003878_abnormal_ear_physiology | 1.99268058 |
32 | MP0002419_abnormal_innate_immunity | 1.91058629 |
33 | MP0009672_abnormal_birth_weight | 1.88561401 |
34 | MP0003329_amyloid_beta_deposits | 1.87704084 |
35 | MP0008057_abnormal_DNA_replication | 1.86472685 |
36 | MP0003718_maternal_effect | 1.82657999 |
37 | MP0005083_abnormal_biliary_tract | 1.80899448 |
38 | MP0005167_abnormal_blood-brain_barrier | 1.73210353 |
39 | MP0010329_abnormal_lipoprotein_level | 1.70291460 |
40 | * MP0003634_abnormal_glial_cell | 1.66257112 |
41 | MP0004147_increased_porphyrin_level | 1.58011993 |
42 | MP0003724_increased_susceptibility_to | 1.56692924 |
43 | MP0004957_abnormal_blastocyst_morpholog | 1.55736596 |
44 | MP0003136_yellow_coat_color | 1.51761286 |
45 | MP0003303_peritoneal_inflammation | 1.51601531 |
46 | MP0003075_altered_response_to | 1.50046500 |
47 | MP0003436_decreased_susceptibility_to | 1.49074854 |
48 | MP0005647_abnormal_sex_gland | 1.48119181 |
49 | MP0002118_abnormal_lipid_homeostasis | 1.47370761 |
50 | MP0005464_abnormal_platelet_physiology | 1.46573926 |
51 | MP0002837_dystrophic_cardiac_calcinosis | 1.45080168 |
52 | MP0004185_abnormal_adipocyte_glucose | 1.44974011 |
53 | MP0001485_abnormal_pinna_reflex | 1.44502013 |
54 | MP0004381_abnormal_hair_follicle | 1.44459680 |
55 | MP0001851_eye_inflammation | 1.40591512 |
56 | MP0000647_abnormal_sebaceous_gland | 1.39712145 |
57 | MP0003011_delayed_dark_adaptation | 1.39145921 |
58 | MP0000465_gastrointestinal_hemorrhage | 1.38921991 |
59 | MP0001533_abnormal_skeleton_physiology | 1.37033182 |
60 | MP0003186_abnormal_redox_activity | 1.36983536 |
61 | MP0008058_abnormal_DNA_repair | 1.29913906 |
62 | MP0003111_abnormal_nucleus_morphology | 1.28983767 |
63 | MP0005332_abnormal_amino_acid | 1.28806992 |
64 | MP0000343_altered_response_to | 1.25280901 |
65 | MP0001293_anophthalmia | 1.23434313 |
66 | MP0001542_abnormal_bone_strength | 1.22983122 |
67 | MP0008007_abnormal_cellular_replicative | 1.22627706 |
68 | MP0003787_abnormal_imprinting | 1.20242580 |
69 | MP0010307_abnormal_tumor_latency | 1.19480025 |
70 | MP0002736_abnormal_nociception_after | 1.17961103 |
71 | MP0003119_abnormal_digestive_system | 1.16423866 |
72 | MP0002148_abnormal_hypersensitivity_rea | 1.15168082 |
73 | MP0008469_abnormal_protein_level | 1.15049091 |
74 | MP0005164_abnormal_response_to | 1.13403707 |
75 | MP0005000_abnormal_immune_tolerance | 1.13289639 |
76 | MP0005257_abnormal_intraocular_pressure | 1.12670804 |
77 | MP0000609_abnormal_liver_physiology | 1.12188394 |
78 | * MP0003632_abnormal_nervous_system | 1.11947827 |
79 | MP0004947_skin_inflammation | 1.11382298 |
80 | MP0005171_absent_coat_pigmentation | 1.08848162 |
81 | MP0009764_decreased_sensitivity_to | 1.08645216 |
82 | MP0004019_abnormal_vitamin_homeostasis | 1.07300011 |
83 | MP0005025_abnormal_response_to | 1.06846389 |
84 | MP0003567_abnormal_fetal_cardiomyocyte | 1.06201358 |
85 | MP0010094_abnormal_chromosome_stability | 1.03829875 |
86 | MP0006035_abnormal_mitochondrial_morpho | 1.00507665 |
87 | MP0005166_decreased_susceptibility_to | 1.00341756 |
88 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99904205 |
89 | MP0003453_abnormal_keratinocyte_physiol | 0.98820808 |
90 | MP0002295_abnormal_pulmonary_circulatio | 0.98180409 |
91 | MP0002998_abnormal_bone_remodeling | 0.97880685 |
92 | MP0000747_muscle_weakness | 0.97773117 |
93 | * MP0002090_abnormal_vision | 0.96687535 |
94 | MP0005671_abnormal_response_to | 0.95612362 |
95 | MP0003137_abnormal_impulse_conducting | 0.92809537 |
96 | MP0001968_abnormal_touch/_nociception | 0.92064303 |
97 | MP0009763_increased_sensitivity_to | 0.90821152 |
98 | MP0002138_abnormal_hepatobiliary_system | 0.90693887 |
99 | MP0009703_decreased_birth_body | 0.89908978 |
100 | MP0009046_muscle_twitch | 0.88739676 |
101 | MP0001545_abnormal_hematopoietic_system | 0.88280777 |
102 | MP0005397_hematopoietic_system_phenotyp | 0.88280777 |
103 | MP0002111_abnormal_tail_morphology | 0.85871952 |
104 | MP0004142_abnormal_muscle_tone | 0.85797841 |
105 | MP0000383_abnormal_hair_follicle | 0.85716301 |
106 | MP0002452_abnormal_antigen_presenting | 0.85131658 |
107 | MP0008932_abnormal_embryonic_tissue | 0.82398055 |
108 | MP0005408_hypopigmentation | 0.81779282 |
109 | MP0002796_impaired_skin_barrier | 0.81181198 |
110 | MP0003937_abnormal_limbs/digits/tail_de | 0.80834937 |
111 | MP0006292_abnormal_olfactory_placode | 0.80509484 |
112 | MP0003448_altered_tumor_morphology | 0.80319799 |
113 | MP0009785_altered_susceptibility_to | 0.79919530 |
114 | MP0001849_ear_inflammation | 0.79543145 |
115 | * MP0002229_neurodegeneration | 0.78957479 |
116 | MP0001188_hyperpigmentation | 0.78144776 |
117 | MP0005319_abnormal_enzyme/_coenzyme | 0.78015432 |
118 | MP0009765_abnormal_xenobiotic_induced | 0.77801831 |
119 | MP0001853_heart_inflammation | 0.77582670 |
120 | MP0005387_immune_system_phenotype | 0.77542947 |
121 | MP0001790_abnormal_immune_system | 0.77542947 |
122 | MP0002723_abnormal_immune_serum | 0.77243524 |
123 | MP0002653_abnormal_ependyma_morphology | 0.77040494 |
124 | MP0001177_atelectasis | 0.76452938 |
125 | MP0005197_abnormal_uvea_morphology | 0.75652763 |
126 | MP0001835_abnormal_antigen_presentation | 0.75589869 |
127 | MP0003633_abnormal_nervous_system | 0.75479155 |
128 | MP0005595_abnormal_vascular_smooth | 0.73384975 |
129 | * MP0003631_nervous_system_phenotype | 0.73371794 |
130 | MP0001730_embryonic_growth_arrest | 0.72821884 |
131 | MP0003566_abnormal_cell_adhesion | 0.70904259 |
132 | MP0005551_abnormal_eye_electrophysiolog | 0.70273705 |
133 | MP0010678_abnormal_skin_adnexa | 0.69833254 |
134 | MP0001845_abnormal_inflammatory_respons | 0.69183816 |
135 | MP0005410_abnormal_fertilization | 0.68693097 |
136 | MP0004130_abnormal_muscle_cell | 0.68459490 |
137 | MP0001661_extended_life_span | 0.68375412 |
138 | MP0002933_joint_inflammation | 0.67580177 |
139 | MP0001958_emphysema | 0.67509549 |
140 | MP0001666_abnormal_nutrient_absorption | 0.66402387 |
141 | MP0000358_abnormal_cell_content/ | 0.66023311 |
142 | MP0002084_abnormal_developmental_patter | 0.65427866 |
143 | MP0004883_abnormal_blood_vessel | 0.64861922 |
144 | MP0005310_abnormal_salivary_gland | 0.64038888 |
145 | MP0004510_myositis | 0.63735935 |
146 | MP0000598_abnormal_liver_morphology | 0.63387958 |
147 | MP0008873_increased_physiological_sensi | 0.62764594 |
148 | MP0004885_abnormal_endolymph | 0.61538772 |
149 | MP0003121_genomic_imprinting | 0.61282942 |
150 | MP0005390_skeleton_phenotype | 0.60960239 |
151 | MP0002085_abnormal_embryonic_tissue | 0.60897675 |
152 | MP0001243_abnormal_dermal_layer | 0.60860615 |
153 | MP0009643_abnormal_urine_homeostasis | 0.60077415 |
154 | MP0002277_abnormal_respiratory_mucosa | 0.59869072 |
155 | MP0001486_abnormal_startle_reflex | 0.59838881 |
156 | MP0002733_abnormal_thermal_nociception | 0.59223872 |
157 | MP0005165_increased_susceptibility_to | 0.59172263 |
158 | MP0004270_analgesia | 0.59155925 |
159 | MP0010352_gastrointestinal_tract_polyps | 0.59029924 |
160 | * MP0001324_abnormal_eye_pigmentation | 0.58920437 |
161 | MP0004742_abnormal_vestibular_system | 0.57785031 |
162 | MP0005379_endocrine/exocrine_gland_phen | 0.56870440 |
163 | MP0005380_embryogenesis_phenotype | 0.56507707 |
164 | MP0001672_abnormal_embryogenesis/_devel | 0.56507707 |
165 | MP0000371_diluted_coat_color | 0.56400366 |
166 | MP0005395_other_phenotype | 0.55525187 |
167 | MP0001984_abnormal_olfaction | 0.52645090 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Axonal loss (HP:0003447) | 5.51314920 |
2 | Systemic lupus erythematosus (HP:0002725) | 5.22900049 |
3 | Neurofibrillary tangles (HP:0002185) | 5.05541012 |
4 | Vacuolated lymphocytes (HP:0001922) | 4.46515371 |
5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.36900341 |
6 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.36900341 |
7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.36900341 |
8 | Abnormality of the labia minora (HP:0012880) | 4.33094461 |
9 | * Increased cerebral lipofuscin (HP:0011813) | 4.29777759 |
10 | Multiple enchondromatosis (HP:0005701) | 4.24925156 |
11 | Complement deficiency (HP:0004431) | 4.03734086 |
12 | Abnormality of macrophages (HP:0004311) | 3.93759000 |
13 | Glomerulonephritis (HP:0000099) | 3.88750406 |
14 | Xanthomatosis (HP:0000991) | 3.87991091 |
15 | Septo-optic dysplasia (HP:0100842) | 3.86329859 |
16 | Hyperlipoproteinemia (HP:0010980) | 3.83405350 |
17 | Hepatosplenomegaly (HP:0001433) | 3.70621699 |
18 | Cerebral inclusion bodies (HP:0100314) | 3.64510377 |
19 | Colon cancer (HP:0003003) | 3.61005988 |
20 | * Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.58327246 |
21 | Peripheral demyelination (HP:0011096) | 3.53022611 |
22 | Dysostosis multiplex (HP:0000943) | 3.52401160 |
23 | Abolished electroretinogram (ERG) (HP:0000550) | 3.49902276 |
24 | Parakeratosis (HP:0001036) | 3.48413997 |
25 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.44404653 |
26 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.43364975 |
27 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.43364975 |
28 | Recurrent abscess formation (HP:0002722) | 3.38676175 |
29 | Abnormality of complement system (HP:0005339) | 3.27875098 |
30 | Spastic diplegia (HP:0001264) | 3.19656836 |
31 | Inappropriate behavior (HP:0000719) | 3.19211806 |
32 | Choanal stenosis (HP:0000452) | 3.15396449 |
33 | Protruding tongue (HP:0010808) | 3.15353726 |
34 | Recurrent bacterial skin infections (HP:0005406) | 3.14906172 |
35 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.12300490 |
36 | Loss of speech (HP:0002371) | 3.10720856 |
37 | * Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.10430151 |
38 | Genetic anticipation (HP:0003743) | 3.05337653 |
39 | Intrahepatic cholestasis (HP:0001406) | 3.00159167 |
40 | Supranuclear gaze palsy (HP:0000605) | 2.98773693 |
41 | Prolonged neonatal jaundice (HP:0006579) | 2.98753117 |
42 | Disinhibition (HP:0000734) | 2.96986032 |
43 | Homocystinuria (HP:0002156) | 2.94981664 |
44 | Abnormality of homocysteine metabolism (HP:0010919) | 2.94981664 |
45 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.90287825 |
46 | Myocardial infarction (HP:0001658) | 2.89938295 |
47 | Thick nail (HP:0001805) | 2.86602317 |
48 | Joint hemorrhage (HP:0005261) | 2.78761030 |
49 | Amyloidosis (HP:0011034) | 2.78302595 |
50 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.73040388 |
51 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.72705091 |
52 | Deep venous thrombosis (HP:0002625) | 2.70757175 |
53 | Neuronal loss in central nervous system (HP:0002529) | 2.68347088 |
54 | Stenosis of the external auditory canal (HP:0000402) | 2.65934085 |
55 | Hyperglycinuria (HP:0003108) | 2.65031955 |
56 | Carpal bone hypoplasia (HP:0001498) | 2.64238579 |
57 | Eczematoid dermatitis (HP:0000976) | 2.61513161 |
58 | Spastic paraparesis (HP:0002313) | 2.61122143 |
59 | Premature rupture of membranes (HP:0001788) | 2.58002276 |
60 | Hematochezia (HP:0002573) | 2.54541445 |
61 | Hepatoblastoma (HP:0002884) | 2.54136620 |
62 | Ependymoma (HP:0002888) | 2.53848877 |
63 | Hypoplasia of the pons (HP:0012110) | 2.52801215 |
64 | Abnormality of the corticospinal tract (HP:0002492) | 2.52407404 |
65 | Short hallux (HP:0010109) | 2.51538141 |
66 | Onion bulb formation (HP:0003383) | 2.50750539 |
67 | Prolonged partial thromboplastin time (HP:0003645) | 2.48253437 |
68 | Paraparesis (HP:0002385) | 2.47710829 |
69 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.46026274 |
70 | Hyperglycinemia (HP:0002154) | 2.45003447 |
71 | Progressive neurologic deterioration (HP:0002344) | 2.44975137 |
72 | Hypoalphalipoproteinemia (HP:0003233) | 2.44120657 |
73 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.43677789 |
74 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.40789946 |
75 | Pathologic fracture (HP:0002756) | 2.40641079 |
76 | Retinal atrophy (HP:0001105) | 2.39460205 |
77 | Abnormality of the pons (HP:0007361) | 2.38786459 |
78 | Mutism (HP:0002300) | 2.38391313 |
79 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.36716963 |
80 | Spastic tetraparesis (HP:0001285) | 2.35973496 |
81 | Cortical dysplasia (HP:0002539) | 2.33641319 |
82 | Abnormality of glycine metabolism (HP:0010895) | 2.33164605 |
83 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.33164605 |
84 | Progressive inability to walk (HP:0002505) | 2.33130761 |
85 | Autoimmune thrombocytopenia (HP:0001973) | 2.32430579 |
86 | Increased serum ferritin (HP:0003281) | 2.30519169 |
87 | Inability to walk (HP:0002540) | 2.30081696 |
88 | Mucopolysacchariduria (HP:0008155) | 2.27122302 |
89 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.27122302 |
90 | Bilateral microphthalmos (HP:0007633) | 2.25679543 |
91 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.24753363 |
92 | Upper motor neuron abnormality (HP:0002127) | 2.22969843 |
93 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.22112088 |
94 | Conjunctival telangiectasia (HP:0000524) | 2.21688662 |
95 | Hypercholesterolemia (HP:0003124) | 2.18092964 |
96 | Abnormality of serum amino acid levels (HP:0003112) | 2.16804976 |
97 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.14922450 |
98 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.14922450 |
99 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.14922450 |
100 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.14566138 |
101 | Stomach cancer (HP:0012126) | 2.14006891 |
102 | Cerebral hypomyelination (HP:0006808) | 2.13384669 |
103 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.11570417 |
104 | Abnormality of iron homeostasis (HP:0011031) | 2.10539254 |
105 | Progressive cerebellar ataxia (HP:0002073) | 2.10117669 |
106 | Slow saccadic eye movements (HP:0000514) | 2.09927042 |
107 | Epidermoid cyst (HP:0200040) | 2.09323878 |
108 | Birth length less than 3rd percentile (HP:0003561) | 2.07773992 |
109 | Agnosia (HP:0010524) | 2.07054162 |
110 | Peripheral hypomyelination (HP:0007182) | 2.06761935 |
111 | Breast aplasia (HP:0100783) | 2.06381954 |
112 | Optic nerve hypoplasia (HP:0000609) | 2.05487238 |
113 | Purpura (HP:0000979) | 2.05023095 |
114 | Urinary incontinence (HP:0000020) | 2.04950934 |
115 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.04401823 |
116 | Myelomeningocele (HP:0002475) | 2.03563289 |
117 | Embryonal renal neoplasm (HP:0011794) | 2.02843335 |
118 | Prostate neoplasm (HP:0100787) | 2.02769901 |
119 | Absent septum pellucidum (HP:0001331) | 2.02107829 |
120 | Fused cervical vertebrae (HP:0002949) | 2.01952198 |
121 | Gaze-evoked nystagmus (HP:0000640) | 2.00027847 |
122 | Erythroderma (HP:0001019) | 1.99544003 |
123 | Recurrent skin infections (HP:0001581) | 1.96741079 |
124 | Gastrointestinal carcinoma (HP:0002672) | 1.96039233 |
125 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.96039233 |
126 | Cellular immunodeficiency (HP:0005374) | 1.94326719 |
127 | Sensory axonal neuropathy (HP:0003390) | 1.93743863 |
128 | Maternal diabetes (HP:0009800) | 1.93061333 |
129 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.92723818 |
130 | Osteolytic defects of the hand bones (HP:0009699) | 1.92723818 |
131 | Abnormality of the common coagulation pathway (HP:0010990) | 1.91143275 |
132 | Nephritis (HP:0000123) | 1.90350881 |
133 | Pendular nystagmus (HP:0012043) | 1.90218720 |
134 | Abnormal gallbladder morphology (HP:0012437) | 1.90082031 |
135 | Hypolipoproteinemia (HP:0010981) | 1.89663955 |
136 | Opisthotonus (HP:0002179) | 1.88487941 |
137 | Abnormality of methionine metabolism (HP:0010901) | 1.87377241 |
138 | Apathy (HP:0000741) | 1.84738373 |
139 | Anencephaly (HP:0002323) | 1.84020440 |
140 | Steatorrhea (HP:0002570) | 1.83490558 |
141 | Protuberant abdomen (HP:0001538) | 1.83178015 |
142 | Personality changes (HP:0000751) | 1.82690236 |
143 | Hypophosphatemic rickets (HP:0004912) | 1.82094945 |
144 | Global brain atrophy (HP:0002283) | 1.81633161 |
145 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81512880 |
146 | Abnormality of glycolysis (HP:0004366) | 1.81050445 |
147 | Increased serum pyruvate (HP:0003542) | 1.81050445 |
148 | Polyphagia (HP:0002591) | 1.80212114 |
149 | Abnormality of the septum pellucidum (HP:0007375) | 1.79874089 |
150 | Methylmalonic aciduria (HP:0012120) | 1.79718694 |
151 | Disproportionate tall stature (HP:0001519) | 1.79500863 |
152 | Diminished motivation (HP:0000745) | 1.79164519 |
153 | Ileus (HP:0002595) | 1.77373400 |
154 | Abnormal gallbladder physiology (HP:0012438) | 1.77081671 |
155 | Cholecystitis (HP:0001082) | 1.77081671 |
156 | Selective tooth agenesis (HP:0001592) | 1.76646210 |
157 | Cholelithiasis (HP:0001081) | 1.76598310 |
158 | Stomatitis (HP:0010280) | 1.76197583 |
159 | Amaurosis fugax (HP:0100576) | 1.73830337 |
160 | Esophageal atresia (HP:0002032) | 1.73765950 |
161 | Absent hair (HP:0002298) | 1.72402353 |
162 | Uterine neoplasm (HP:0010784) | 1.71952828 |
163 | Diplopia (HP:0000651) | 1.71487192 |
164 | Abnormality of binocular vision (HP:0011514) | 1.71487192 |
165 | Meckel diverticulum (HP:0002245) | 1.70164718 |
166 | Biliary tract neoplasm (HP:0100574) | 1.69559353 |
167 | Macroglossia (HP:0000158) | 1.69387524 |
168 | Chronic bronchitis (HP:0004469) | 1.67786927 |
169 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.67624903 |
170 | Hypogonadotrophic hypogonadism (HP:0000044) | 1.67327831 |
171 | Dysphonia (HP:0001618) | 1.64544927 |
172 | Pancreatic cysts (HP:0001737) | 1.64094482 |
173 | Abnormality of the ileum (HP:0001549) | 1.63714008 |
174 | Erectile abnormalities (HP:0100639) | 1.63323647 |
175 | Rhabdomyosarcoma (HP:0002859) | 1.62052630 |
176 | Medulloblastoma (HP:0002885) | 1.60306553 |
177 | Depressed nasal tip (HP:0000437) | 1.59367512 |
178 | Bronchomalacia (HP:0002780) | 1.59111779 |
179 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.57695069 |
180 | * Restlessness (HP:0000711) | 1.57452078 |
181 | Absent eyebrow (HP:0002223) | 1.55233454 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ACVR1B | 4.93116407 |
2 | PBK | 4.25505441 |
3 | EPHB1 | 4.07149405 |
4 | TNIK | 3.92403813 |
5 | STK39 | 3.64513032 |
6 | MKNK2 | 3.31618719 |
7 | PKN1 | 2.89513962 |
8 | MKNK1 | 2.51730520 |
9 | FRK | 2.50823666 |
10 | OXSR1 | 2.49276024 |
11 | MET | 2.42933808 |
12 | MAPKAPK5 | 2.39548948 |
13 | ZAK | 2.30453270 |
14 | TAF1 | 2.29480253 |
15 | WNK3 | 2.23364686 |
16 | CDK19 | 2.23203991 |
17 | IRAK4 | 2.15268457 |
18 | BLK | 2.13829758 |
19 | IRAK2 | 2.00232408 |
20 | FGR | 1.99688893 |
21 | CDC7 | 1.99238810 |
22 | TTK | 1.95096938 |
23 | TGFBR2 | 1.92959435 |
24 | NUAK1 | 1.89618242 |
25 | TGFBR1 | 1.84325786 |
26 | IRAK3 | 1.81778784 |
27 | BMPR1B | 1.81304517 |
28 | TBK1 | 1.76038948 |
29 | EPHA2 | 1.75557491 |
30 | KIT | 1.68645938 |
31 | BMX | 1.68591272 |
32 | TYK2 | 1.64497663 |
33 | STK38L | 1.62707952 |
34 | CSF1R | 1.58239552 |
35 | MAPK15 | 1.57176291 |
36 | GRK7 | 1.51656516 |
37 | VRK2 | 1.47539239 |
38 | PLK3 | 1.45838201 |
39 | ABL2 | 1.43680621 |
40 | MAP3K9 | 1.41591228 |
41 | TESK2 | 1.36588979 |
42 | ERBB4 | 1.36258848 |
43 | DYRK3 | 1.31737988 |
44 | CAMK1D | 1.30162990 |
45 | MST1R | 1.25953609 |
46 | ERN1 | 1.23051745 |
47 | NLK | 1.20263714 |
48 | LIMK1 | 1.17852297 |
49 | GSK3A | 1.17510736 |
50 | DAPK2 | 1.16069490 |
51 | PRPF4B | 1.14893358 |
52 | BCR | 1.14537162 |
53 | CLK1 | 1.14491792 |
54 | ALK | 1.13015078 |
55 | IKBKB | 1.12858734 |
56 | IRAK1 | 1.09395673 |
57 | STK3 | 1.09223426 |
58 | TIE1 | 1.09072988 |
59 | NME2 | 1.08015940 |
60 | NEK6 | 1.07790680 |
61 | CSNK1G3 | 1.04052061 |
62 | FES | 1.01675725 |
63 | PDPK1 | 1.01370177 |
64 | MAP2K2 | 0.98515212 |
65 | DYRK2 | 0.98283376 |
66 | CSK | 0.97945430 |
67 | TEC | 0.96547157 |
68 | TAOK3 | 0.96164815 |
69 | NTRK1 | 0.93854371 |
70 | TAOK2 | 0.92481167 |
71 | MAPK12 | 0.91446653 |
72 | ADRBK2 | 0.90515851 |
73 | TRPM7 | 0.89422595 |
74 | CAMK1G | 0.87690725 |
75 | CSNK1A1L | 0.87445062 |
76 | PIM1 | 0.86460706 |
77 | PDK2 | 0.86010322 |
78 | HCK | 0.84708029 |
79 | FLT3 | 0.84490717 |
80 | BUB1 | 0.82874177 |
81 | PRKCG | 0.82686683 |
82 | CSNK1G1 | 0.80968470 |
83 | IKBKE | 0.80217786 |
84 | SGK223 | 0.79422562 |
85 | SGK494 | 0.79422562 |
86 | STK4 | 0.78513133 |
87 | PLK1 | 0.78442520 |
88 | FGFR2 | 0.77824981 |
89 | STK24 | 0.77459329 |
90 | PNCK | 0.77248962 |
91 | MOS | 0.76937044 |
92 | ROCK2 | 0.76665336 |
93 | CAMK2B | 0.74779975 |
94 | CAMK2D | 0.73558654 |
95 | PIM2 | 0.72260893 |
96 | BMPR2 | 0.70748660 |
97 | FGFR1 | 0.69696965 |
98 | BRSK2 | 0.69446100 |
99 | DYRK1A | 0.68788011 |
100 | CAMK2G | 0.68636034 |
101 | PRKD1 | 0.67775454 |
102 | TYRO3 | 0.65688833 |
103 | INSRR | 0.65006895 |
104 | RPS6KA5 | 0.64590865 |
105 | EGFR | 0.63239958 |
106 | CSNK1G2 | 0.62834386 |
107 | PLK4 | 0.62695340 |
108 | TRIM28 | 0.61711020 |
109 | CASK | 0.59519972 |
110 | PAK1 | 0.59439735 |
111 | FGFR4 | 0.57316320 |
112 | MAPK7 | 0.57021237 |
113 | STK10 | 0.56867931 |
114 | VRK1 | 0.55741799 |
115 | MAP3K11 | 0.54996238 |
116 | WNK1 | 0.54970814 |
117 | EEF2K | 0.54764060 |
118 | LCK | 0.54613960 |
119 | LYN | 0.53690778 |
120 | ARAF | 0.53485861 |
121 | MAP3K14 | 0.53256315 |
122 | PRKCD | 0.52959432 |
123 | BCKDK | 0.52918417 |
124 | JAK2 | 0.51028631 |
125 | MAPKAPK2 | 0.49905688 |
126 | PRKCE | 0.49309139 |
127 | MST4 | 0.49210634 |
128 | ABL1 | 0.49181404 |
129 | RIPK4 | 0.48049187 |
130 | LATS1 | 0.47851030 |
131 | RPS6KA1 | 0.46997094 |
132 | EIF2AK1 | 0.46758716 |
133 | ITK | 0.46652554 |
134 | GRK1 | 0.45205268 |
135 | FYN | 0.44750425 |
136 | JAK1 | 0.44658446 |
137 | SRPK1 | 0.44526360 |
138 | CHEK2 | 0.44043392 |
139 | RPS6KA6 | 0.42695819 |
140 | SGK2 | 0.42650606 |
141 | TSSK6 | 0.41773207 |
142 | STK11 | 0.41764019 |
143 | MAP3K3 | 0.41112049 |
144 | DAPK1 | 0.39921108 |
145 | IGF1R | 0.38043335 |
146 | PIK3CG | 0.37249057 |
147 | PRKCQ | 0.36816790 |
148 | INSR | 0.36179291 |
149 | PRKG2 | 0.35764375 |
150 | MATK | 0.35711599 |
151 | CDC42BPA | 0.35678915 |
152 | ERBB2 | 0.35483311 |
153 | ATM | 0.34630877 |
154 | DAPK3 | 0.33957474 |
155 | STK16 | 0.32915566 |
156 | CSNK1A1 | 0.31954843 |
157 | RPS6KC1 | 0.28943554 |
158 | RPS6KL1 | 0.28943554 |
159 | MAP3K4 | 0.28362006 |
160 | RPS6KA2 | 0.27971298 |
161 | CAMK1 | 0.27320569 |
162 | ATR | 0.26342872 |
163 | TAOK1 | 0.26113195 |
164 | CSNK1D | 0.24783871 |
165 | CSNK2A1 | 0.23550291 |
166 | PRKDC | 0.23365761 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.48606211 |
2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.48891052 |
3 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.34981286 |
4 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.13761389 |
5 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.97112606 |
6 | Lysosome_Homo sapiens_hsa04142 | 2.87950018 |
7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.56230625 |
8 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.48418934 |
9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.42930775 |
10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.37371080 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.27924421 |
12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.26903373 |
13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.21042336 |
14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.20126333 |
15 | Other glycan degradation_Homo sapiens_hsa00511 | 2.13797070 |
16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.10606074 |
17 | RNA polymerase_Homo sapiens_hsa03020 | 1.97324332 |
18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.96688527 |
19 | Homologous recombination_Homo sapiens_hsa03440 | 1.84335770 |
20 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.80987161 |
21 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.80040273 |
22 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.74982014 |
23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.74637988 |
24 | Basal transcription factors_Homo sapiens_hsa03022 | 1.74313149 |
25 | Asthma_Homo sapiens_hsa05310 | 1.71254204 |
26 | Mismatch repair_Homo sapiens_hsa03430 | 1.63109888 |
27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.62236259 |
28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.58661581 |
29 | Phagosome_Homo sapiens_hsa04145 | 1.55473063 |
30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.47269328 |
31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43290782 |
32 | Malaria_Homo sapiens_hsa05144 | 1.38621370 |
33 | Peroxisome_Homo sapiens_hsa04146 | 1.37924948 |
34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.37751266 |
35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.32622019 |
36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.32440492 |
37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.31071487 |
38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.28566201 |
39 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.25162252 |
40 | Prion diseases_Homo sapiens_hsa05020 | 1.25130427 |
41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.23531739 |
42 | Phototransduction_Homo sapiens_hsa04744 | 1.22682744 |
43 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.18599184 |
44 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.17324421 |
45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.15716927 |
46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15422875 |
47 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.14348191 |
48 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13730012 |
49 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.12901586 |
50 | Pertussis_Homo sapiens_hsa05133 | 1.12798712 |
51 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.11519323 |
52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.10904206 |
53 | Retinol metabolism_Homo sapiens_hsa00830 | 1.09797055 |
54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07681046 |
55 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.04264987 |
56 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.04173993 |
57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.03523914 |
58 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.03205314 |
59 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.00894579 |
60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.99156694 |
61 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.98636824 |
62 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.98416527 |
63 | ABC transporters_Homo sapiens_hsa02010 | 0.96302636 |
64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.93818858 |
65 | Nicotine addiction_Homo sapiens_hsa05033 | 0.91201219 |
66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90127402 |
67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.89994794 |
68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.89073847 |
69 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.88034192 |
70 | RNA degradation_Homo sapiens_hsa03018 | 0.82224593 |
71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.82035834 |
72 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.81975593 |
73 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81138085 |
74 | Leishmaniasis_Homo sapiens_hsa05140 | 0.80775688 |
75 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.79040149 |
76 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76865020 |
77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76860063 |
78 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.74524075 |
79 | DNA replication_Homo sapiens_hsa03030 | 0.73974222 |
80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73212822 |
81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71662572 |
82 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71034935 |
83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69748669 |
84 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.68255224 |
85 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68190681 |
86 | Taste transduction_Homo sapiens_hsa04742 | 0.68112481 |
87 | Proteasome_Homo sapiens_hsa03050 | 0.67507670 |
88 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66594987 |
89 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.66552459 |
90 | Tuberculosis_Homo sapiens_hsa05152 | 0.66408960 |
91 | Lysine degradation_Homo sapiens_hsa00310 | 0.65253006 |
92 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.63787013 |
93 | Mineral absorption_Homo sapiens_hsa04978 | 0.61740293 |
94 | RNA transport_Homo sapiens_hsa03013 | 0.61664064 |
95 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.60918153 |
96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59928576 |
97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55866891 |
98 | Allograft rejection_Homo sapiens_hsa05330 | 0.55717720 |
99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54398868 |
100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54234359 |
101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53241283 |
102 | Tight junction_Homo sapiens_hsa04530 | 0.51228628 |
103 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50705124 |
104 | Sulfur relay system_Homo sapiens_hsa04122 | 0.49693682 |
105 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49639933 |
106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48544326 |
107 | Bile secretion_Homo sapiens_hsa04976 | 0.48033979 |
108 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.47994510 |
109 | Endocytosis_Homo sapiens_hsa04144 | 0.46998325 |
110 | Salmonella infection_Homo sapiens_hsa05132 | 0.45948646 |
111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45684474 |
112 | Purine metabolism_Homo sapiens_hsa00230 | 0.45526039 |
113 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.45282342 |
114 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43572438 |
115 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42491136 |
116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40955320 |
117 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.39588136 |
118 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.39319575 |
119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39149723 |
120 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.37865966 |
121 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37080520 |
122 | Bladder cancer_Homo sapiens_hsa05219 | 0.35140579 |
123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34502072 |
124 | Legionellosis_Homo sapiens_hsa05134 | 0.33538137 |
125 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.33260076 |
126 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.32477521 |
127 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31929304 |
128 | Base excision repair_Homo sapiens_hsa03410 | 0.31788359 |
129 | Apoptosis_Homo sapiens_hsa04210 | 0.31142858 |
130 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.30896265 |
131 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.30168231 |
132 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.29674912 |
133 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.29347382 |
134 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29295073 |
135 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.28733987 |
136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27739177 |
137 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.27610373 |
138 | Long-term depression_Homo sapiens_hsa04730 | 0.27509112 |
139 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.27334782 |
140 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.26378140 |
141 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.26056044 |
142 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.25883795 |
143 | Hepatitis C_Homo sapiens_hsa05160 | 0.25340567 |
144 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.25215435 |
145 | Amoebiasis_Homo sapiens_hsa05146 | 0.24687814 |
146 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.24677117 |
147 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.23229847 |
148 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.20574710 |
149 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.19718545 |
150 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.19479190 |